rs796053373
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001032221.6(STXBP1):c.1651C>A(p.Arg551Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R551C) has been classified as Pathogenic.
Frequency
Consequence
NM_001032221.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STXBP1 | NM_003165.6 | c.1651C>A | p.Arg551Ser | missense_variant | 18/20 | ENST00000373302.8 | NP_003156.1 | |
STXBP1 | NM_001032221.6 | c.1651C>A | p.Arg551Ser | missense_variant | 18/19 | ENST00000373299.5 | NP_001027392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STXBP1 | ENST00000373302.8 | c.1651C>A | p.Arg551Ser | missense_variant | 18/20 | 1 | NM_003165.6 | ENSP00000362399.3 | ||
STXBP1 | ENST00000373299.5 | c.1651C>A | p.Arg551Ser | missense_variant | 18/19 | 1 | NM_001032221.6 | ENSP00000362396.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 11, 2012 | p.Arg551Ser (CGC>AGC): c.1651 C>A in exon 18 of the STXBP1 gene (NM_003165.2)The Arg551Ser missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. However, a different amino acid substitution at the same codon, Arg551Cys, was previously reported as a de novo mutation in a patient with an autism spectrum disorder, although no additional information was provided regarding the patient's phenotype (Neale et al., 2012). The NHLBI ESP Exome Variant Project has not identified Arg551Ser in approximately 6,500 individuals of European or African American ethnicity, indicating that it is not a common benign variant in these populations. The amino acid substitution is non-conservative, as a positively charged Arginine residue is replaced by an uncharged Serine residue. Arg551Ser alters a highly conserved position in the protein, and other missense mutations have been published in this region of the protein in association with epilepsy. Additionally, multiple in silico algorithms predict that Arg551Ser is damaging to protein structure/function. This variant has been observed de novo without verified parentage; The variant is found in EPILEPSY panel(s). - |
Developmental and epileptic encephalopathy, 4 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory of Medical Genetics, National & Kapodistrian University of Athens | Apr 03, 2018 | PM2,PM5,PP2,PP3,PP5 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at